A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery

Status:	Completed
Conditions:	Cardiology, Cardiology, Orthopedic
Therapuetic Areas:	Cardiology / Vascular Diseases, Orthopedics / Podiatry
Healthy:	No
Age Range:	18 - Any
Updated:	4/21/2016
Start Date:	April 2009
End Date:	August 2010

A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery

The purpose of this study is to evaluate the efficacy and safety of various doses of YM150
(the experimental drug) compared to enoxaparin in the prevention of venous thromboembolism
in patients that are undergoing elective hip replacement surgery.

Inclusion Criteria:

- Subject is scheduled for elective hip replacement surgery

Exclusion Criteria:

- Subject has active bleeding or any condition associated with increased risk of
bleeding

- Subject has had major trauma or surgery within 3 months before planned hip
replacement surgery or requires major surgery or other invasive procedures with
potential for uncontrolled bleeding during the study

- Subject has had an MI or stroke within 3 months before planned hip replacement
surgery

We found this trial at

sites

Clinical Trial Facility in Sarasota Florida

Sarasota, Florida 34239

from

Sarasota, FL